investor_presentation
Cassini Resources
Loading viewer...
investor_presentation
Format: PDF investor_presentation
Halozyme presents its June 2024 investor update covering financial guidance through 2028, ENHANZE® drug delivery technology patent developments, and collaboration expansion plans. The presentation outlines expectations for revenue growth, adjusted EBITDA margins, and royalty revenues from partner commercialization efforts.
investor_presentation
26 Pages
investor_presentation
115 Pages
Anika Therapeutics
Honeywell International Investor Presentation — February 2018
investor_presentationinvestor_presentation
25 Pages
Honeywell International Inc.
investor_presentation
Cassini Resources